Why Syndax Pharmaceuticals Inc. (SNDX) is Rising high Right Now. Here is what you need to know
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors, reported its financial results for the first quarter completed on March 31, 2021. SNDX stock increased immensely adjacent to the news. At last check-in after-market trading, shares of Syndax Pharmaceuticals Inc. (SNDX) were up 5.99% […]